GlaxoSmithKline
,
Stevenage, Hertfordshire
Senior Scientific Director Global Medical Affair
Overview
We're looking for a candidate to fill this position in an exciting company. Plays an integral role in building/ optimising the Global Medical Affairs Plan (MAP) and Integrated Evidence Plan (IEP) for the relevant asset/ indication(s). Works closely with the PPL and MDL to optimise development plans. Drives delivery of designated above-country elements of the MAP e.g. Advisory Boards; Symposia. Partners with commercial colleagues to optimise brand campaigns and launches in the Franchise LOCs. Drives the development and approval of promotional and training materials. Delivers the evidence needs for that asset on behalf of the GMAL in partnership with R&D: Drives the efficient working of the Integrated Evidence Team; ensuring insights from Franchise LOCs are integrated appropriately to inform the IEP. Reviews local the company-sponsored and Investigator Sponsored Study (ISS) proposals from Franchise LOCs to assess their scientific merit and strategic need, liaising with R&D technical experts. Accountable for the development of assigned Franchise study protocols. Drives excellence in Scientific Engagement (SE) with key stakeholders (HCPs, Patients, Payors and Regulators) to gain a deep understanding of customer needs. Deputizes regularly for the GMAL as required. PharmD, PhD or equivalent Pharmaceutical Industry and/or clinical experience in oncology, preferably Immuno-Oncology. Significant disease/therapeutic area knowledge. Significant experience in Medical Affairs and life cycle management preferred, including launch support requirements. Robust understanding of promotional codes/ regulations; previous involvement in review and approval processes. Highly developed leadership, networking, communication and influencing skills to work effectively in a complex matrix environment. Demonstrated ability to build strong internal and external networks. Prior above country experience advantageous.